Amarin reported $1.43M in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
DBV Technologies DBVT:US USD -38017000 20M
Alnylam Pharmaceuticals ALNY:US USD -188614000 69.43M
Amarin AMRN:US USD 1.43M 39.05M
AstraZeneca AZN:LN USD 1.84B 429M
Biocryst Pharmaceuticals BCRX:US USD -46311000 28.87M
Esperion Therapeutics ESPR:US USD -42513000 890K
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Halozyme Therapeutics HALO:US USD 75.91M 7.78M
Heron Therapeutics HRTX:US USD -41882000 7.62M
Intercept Pharmaceuticals ICPT:US USD -17985000 7.84M
JAZZ PHA JAZZ:US USD -263386000 462.6M
Nektar Therapeutics NKTR:US USD -40889000 3.42M
Neurocrine Biosciences NBIX:US USD 103.4M 15.6M
Novartis NOVN:VX USD 3.1B 228M
Teva Pharmaceutical Industries TEVA:US USD 999M 259M